Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
RinaPharm AB
AB
Active
Org 5591526693
Smala Gränd 3, 111 39
Stockholm
Other non-specialised retail sale
·
NACE 4712
Est. 2018 · 8 years old
0 employees
Overvåg
Share
Sweden
/
Companies
/
Other non-specialised retail sale
/
RinaPharm AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2020
0M
0%
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
0
0
0
0
0
Staff expenses
—
—
—
—
—
EBITDA
−15
−24
−16
−39
—
Depreciation & amort.
−0
−0
—
—
—
EBIT
−15
−24
−16
−39
0
Net financials
4 415
—
−357
359
−15
Profit before tax
4 399
−24
−373
320
−15
Tax
−0
−0
—
—
—
Net profit
4 399
−24
−373
320
−15
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
17 888
17 680
17 119
17 244
17 923
Equity
17 888
17 680
17 119
17 244
17 923
Long-term debt
0
0
—
—
—
Short-term debt
0
0
—
—
—
Total debt
—
—
—
—
—
Financial ratios
5-year trend
EBITDA-margin
0.0%
This company
15.8%
Market median
-100% vs market
2020
2024
Soliditetsgrad
100.0%
This company
38.2%
Market median
+162% vs market
2020
2024
Egenkapitalforrentning
-0.1%
This company
18.4%
Market median
-101% vs market
2020
2024
Nettoresultatgrad
-1536400.0%
This company
8.1%
Market median
-18968001% vs market
2020
2024
Aktivomsætning
0.00×
This company
1.12×
Market median
-100% vs market
2020
2024
Gæld/egenkapital
0.00×
This company
0.62×
Market median
+100% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on RinaPharm AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
